Philadelphia, PA4 Active Studies

Hidradenitis Suppurativa Clinical Trials in Philadelphia, PA

Find 4 actively recruiting hidradenitis suppurativa clinical trials in Philadelphia, PA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
2,130
Enrolling

Recruiting Hidradenitis Suppurativa Studies in Philadelphia

About Hidradenitis Suppurativa Clinical Trials in Philadelphia

Hidradenitis suppurativa is a chronic skin condition causing painful lumps under the skin, typically in areas where skin rubs together. It can lead to tunnels under the skin and scarring. Treatment includes antibiotics, biologics, and surgical interventions.

There are currently 4 hidradenitis suppurativa clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 2,130 participants. Research is being sponsored by Children's Hospital Medical Center, Cincinnati, Stanford University, Amgen and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hidradenitis Suppurativa Clinical Trials in Philadelphia — FAQ

Are there hidradenitis suppurativa clinical trials in Philadelphia?

Yes, there are 4 hidradenitis suppurativa clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What hidradenitis suppurativa treatments are being tested?

The 4 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for hidradenitis suppurativa.

Data updated August 29, 2026 from ClinicalTrials.gov